Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 118265
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118265
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118265
Figure 1 Overall survival.
Blue curve: Cohort A; red curve: Cohort B.
Figure 2 Survival curve.
A: Non-elderly subgroup (< 65 years); B: Elderly subgroup(≥ 65 years); C: Survival curve of male subgroup; D: Female subgroup; E: The left-side colon subgroup; F: The right-side colon subgroup; G: The rat sarcoma viral oncogene homolog/B-Raf proto-oncogene, serine/threonine kinase wild-type subgroup; H: The rat sarcoma viral oncogene homolog/B-Raf proto-oncogene, serine/threonine kinase mutation subgroup; I: The liver metastasis local treatment subgroup; J: The non-liver metastasis local treatment subgroup; K: Before the third line treatment subgroup; L: After the third line treatment subgroup; M: The only liver metastasis subgroup; N: The combined with extrahepatic metastasis subgroup. Blue curve: Cohort A; red curve: Cohort B.
- Citation: Bian JY, Sun YX, Wang LF, He WT, Liu CB, Wang XQ, Zhang T. Integrated Chinese and Western medicine prolong survival in colorectal cancer with liver metastasis: A retrospective cohort study. World J Clin Oncol 2026; 17(5): 118265
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/118265.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.118265